SUBSCRIBE
SUBSCRIBE

CRISPR Therapeutics

NEWS
Business
CRISPR To Lose Its CFO In September, Hunt For Successor Begins
July 27, 2017
 · 
1 min read
Biotech Vets Launch Arrakis With $38 Million and Will be Helmed By Biogen Alum Michael Gilman
Drug Development
CRISPR, Editas Medicine and Intellia Fall as Scientific Paper Warns of Unintended Mutations Linked to Gene-Editing
May 31, 2017
 · 
3 min read
Deals
CRISPR’s Surprisingly Low IPO… Why Are Investors Discouraged?
October 21, 2016
 · 
1 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
CRISPR IPO Brings Home $56 Million, Half of What Its Rival Took in Earlier This Year
October 19, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Gene Editing Phenom CRISPR Files for $90 Million IPO
September 12, 2016
 · 
3 min read
Elon Musk Launches Neuroscience Startup to Plug AI Into Your Brain
Business
Bayer and CRISPR Form 80 Employee Joint Venture Named Casebia Therapeutics in Boston Area
August 19, 2016
 · 
3 min read
Business
Top 20 Life Science Startups to Watch in the U.S.
BioSpace is pleased to present its NextGen Bio “Class of 2016.” This list contains 20 life science companies that launched no earlier than 2013 and are headquartered in the United States.
January 26, 2016
 · 
15 min read
 · 
Mark Terry
What You Need to Know About CRISPR
Business
What You Need to Know About CRISPR
December 1, 2015
 · 
5 min read
Business
Vertex Coughs Up $105 Million Upfront to CRISPR for Gene Editing Pact
October 26, 2015
 · 
2 min read
Load More
AWARDS
  • NextGen Class of 2016
JOBS
IN THE PRESS
Job Trends
CRISPR Therapeutics and ViaCyte, Inc. to Start Clinical Trial of the First Gene-Edited Cell Replacement Therapy for Treatment of Type 1 Diabetes-Initiation of patient enrollment expected by year-end-
November 16, 2021
 · 
6 min read
Business
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2021 Financial Results
November 3, 2021
 · 
16 min read
Genetown
CRISPR Therapeutics to Participate in Upcoming Investor Conferences - Nov 02, 2021
November 2, 2021
 · 
1 min read
Business
CRISPR Therapeutics Announces Transition of Chief Financial Officer
October 14, 2021
 · 
3 min read
Drug Development
CRISPR Therapeutics Reports Positive Results from its Phase 1 CARBON Trial of CTX110™ in Relapsed or Refractory CD19+ B-cell malignancies
October 12, 2021
 · 
10 min read
Genetown
CRISPR Therapeutics to Host Virtual Event Highlighting CTX110™ Clinical Data
October 5, 2021
 · 
2 min read
Genetown
CRISPR Therapeutics to Present Preclinical Data at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
October 1, 2021
 · 
2 min read
Genetown
CRISPR Therapeutics to Participate in the Chardan’s 5th Annual Genetic Medicines Conference
September 28, 2021
 · 
1 min read
Genetown
CRISPR Therapeutics to Participate in the Canaccord Genuity 41st Annual Growth Conference
August 5, 2021
 · 
1 min read
Business
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results
July 29, 2021
 · 
16 min read
Load More